Clinical Trials Directory

Trials / Conditions / Chronic Myelogenous Leukemia - Chronic Phase

Chronic Myelogenous Leukemia - Chronic Phase

9 registered clinical trials studyying Chronic Myelogenous Leukemia - Chronic Phase — 4 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingTGRX-678 Chinese Phase III in Chronic Myelogenous Leukemia (CML) Patients
NCT07489755
Shenzhen TargetRx Co., Ltd.Phase 3
Not Yet RecruitingA Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Cl
NCT07091019
Novartis Pharmaceuticals—
RecruitingEvaluation of Advanced Practice Nurse's Management of Patients With Chronic Myeloid Leukemia
NCT06082804
Centre Hospitalier Henri Duffaut - AvignonN/A
RecruitingMCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing
NCT05794880
Medical College of WisconsinN/A
Active Not RecruitingAsciminib Monotherapy, With Dose Escalation, for 2nd and 1st Line Chronic Myelogenous Leukemia
NCT05384587
Novartis PharmaceuticalsPhase 2
CompletedAsciminib in Monotherapy for Chronic Myeloid Leukemia in Chronic Phase (CML-CP) With and Without T315I Mutatio
NCT04666259
Novartis PharmaceuticalsPhase 3
Active Not RecruitingVorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogenei
NCT03842696
University of Michigan Rogel Cancer CenterPhase 1 / Phase 2
CompletedA Study of Dasatinib as First-line Treatment for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia (CML-C
NCT04925141
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Phase 4
TerminatedStudy of Molecular Response in Adult Patients on Nilotinib With Philadelphia Chromosome Positive Chronic Myelo
NCT00644878
Novartis PharmaceuticalsPhase 2